论文部分内容阅读
目的:评估新辅助化疗后隐匿性乳腺癌放射定位(ROLL)保乳术的价值。方法:回顾性分析3年间对我院进行新辅助化疗后使用ROLL-99mTc核素定位保乳术及金属标记物定位保乳术的患者资料,对切除标本重量、切除标本阳性边缘及术后癌转移等情况进行评估。结果:93例ROLL-99mTc核素定位切除标本的平均重量为52(12~158)g,其中有8例切除标本边缘病理检测阳性。108例金属标记物定位切除标本的平均重量为71(46~116)g,其中有16例切除标本边缘病理检测阳性。结论:ROLL-99mTc技术相对于金属标记物定位法在临床上具有很大的可行性,可用于一些新辅助化疗患者的保乳术中。
Objective: To evaluate the value of ROLL breast conserving surgery after neoadjuvant chemotherapy. Methods: The data of patients with ROLL-99mTc radionuclide positioning and breast-conserving surgery with metal markers after neoadjuvant chemotherapy in our hospital over three years were retrospectively analyzed. The resection specimens were collected for the weight of the resected specimens, the positive margins of resected specimens and the postoperative Transfer and other assessment. Results: The average weight of 93 cases of ROLL-99mTc nuclide resection specimens was 52 (12 ~ 158) g, of which 8 cases were positive for edge pathological examination. The average weight of resected specimens of 108 cases of metal markers was 71 (46-116) g, of which 16 cases were positive for marginal pathology. CONCLUSION: The ROLL-99mTc technology is clinically feasible compared with the metal labeling method and can be used in the preservation of some neoadjuvant chemotherapy patients.